FdaApplication
NDA 216903
Identifiers
- fda_app_no: NDA216903
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2023-02-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREVDUO | GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE | 0.6MG/3ML (0.2MG/ML);3MG/3ML (1MG/ML) | SOLUTION;INTRAVENOUS |
1 product